Open Access 01.12.2014 | Original investigation
DPP-4 inhibitor linagliptin ameliorates cardiovascular injury in salt-sensitive hypertensive rats independently of blood glucose and blood pressure
Erschienen in: Cardiovascular Diabetology | Ausgabe 1/2014